Correlation Between Migdal Insurance and Insuline Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Migdal Insurance and Insuline Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Migdal Insurance and Insuline Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Migdal Insurance and Insuline Medical, you can compare the effects of market volatilities on Migdal Insurance and Insuline Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Migdal Insurance with a short position of Insuline Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Migdal Insurance and Insuline Medical.

Diversification Opportunities for Migdal Insurance and Insuline Medical

-0.57
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Migdal and Insuline is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Migdal Insurance and Insuline Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Insuline Medical and Migdal Insurance is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Migdal Insurance are associated (or correlated) with Insuline Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Insuline Medical has no effect on the direction of Migdal Insurance i.e., Migdal Insurance and Insuline Medical go up and down completely randomly.

Pair Corralation between Migdal Insurance and Insuline Medical

Assuming the 90 days trading horizon Migdal Insurance is expected to generate 0.28 times more return on investment than Insuline Medical. However, Migdal Insurance is 3.62 times less risky than Insuline Medical. It trades about 0.35 of its potential returns per unit of risk. Insuline Medical is currently generating about -0.05 per unit of risk. If you would invest  60,930  in Migdal Insurance on September 5, 2024 and sell it today you would earn a total of  7,520  from holding Migdal Insurance or generate 12.34% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Migdal Insurance  vs.  Insuline Medical

 Performance 
       Timeline  
Migdal Insurance 

Risk-Adjusted Performance

37 of 100

 
Weak
 
Strong
Very Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Migdal Insurance are ranked lower than 37 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Migdal Insurance sustained solid returns over the last few months and may actually be approaching a breakup point.
Insuline Medical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Insuline Medical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Insuline Medical is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Migdal Insurance and Insuline Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Migdal Insurance and Insuline Medical

The main advantage of trading using opposite Migdal Insurance and Insuline Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Migdal Insurance position performs unexpectedly, Insuline Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Insuline Medical will offset losses from the drop in Insuline Medical's long position.
The idea behind Migdal Insurance and Insuline Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope